Agios Pharmaceuticals Inc. AGIO
$32.09
▲ +2.58% 24H
About
Agios Pharmaceuticals Inc. is a biopharmaceutical company specializing in cellular metabolism to develop differentiated medicines for rare diseases, with a particular emphasis on classical hematology. The company focuses on creating potentially transformative small-molecule therapies targeting unmet medical needs in he…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees539
TickerAGIO
Statistics
Market Cap$1.90B
Revenue (TTM)$54.0M
Net Income-$412.8M
Net Margin-764.0%
EPS$-7.12
P/E3.82
P/S25.86
P/B1.54
EV/EBITDA-2.16
ROE-32.8%
Dividend Yield—
Price$32.09
Data: Twelve Data · Revenue = mcap / P/S